Whole exome sequencing of extreme morbid obesity patients: Translational implications for obesity and related disorders

Genes

Volumn 5, Issue 3, 2014, Pages 709-725

  Paz Filho, Gilberto ^a   Boguszewski, Margaret C S ^b   Mastronardi, Claudio A ^a   Patel, Hardip R ^a   Johar, Angad S ^a   Chuah, Aaron ^a   Huttley, Gavin A ^a   Boguszewski, Cesar L ^b   Wong, Ma Li ^c   Arcos Burgos, Mauricio ^a   Licinio, Julio ^c  

^a Australian National University   (Australia)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

DNAAF1; Genetics; Leptin melanocortin; LRP2; Megalin; Monogenic; Obesity; Pituitary; UCP2; Whole exome sequencing

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CABERGOLINE; CALCIUM; CHOLESTEROL; CORTICOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INOSINE TRIPHOSPHATE; INSULIN; LEPTIN; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; PROLACTIN; RECOMBINANT GROWTH HORMONE; SELENIUM; SIBUTRAMINE; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE ESTER; TETRAHYDROLIPSTATIN; THYROTROPIN; TRIACYLGLYCEROL; VITAMIN D;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; BONE AGE; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; CILIARY MOTILITY; DISEASE SEVERITY; DNAAF1 GENE; ENZYME METABOLISM; EXOME; FEMALE; FEVER; GENE; GENE MUTATION; GENE ONTOLOGY; GENETIC ANALYSIS; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOPITUITARISM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; LEUKOCYTOSIS; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LRP2 GENE; MAGNESIUM BLOOD LEVEL; MALE; MEDICAL HISTORY; MORBID OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SELENIUM BLOOD LEVEL; SEQUENCE ANALYSIS; SWEATING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UCP2 GENE; VIRAL RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; WEIGHT GAIN; WHOLE EXOME SEQUENCING;

MUS;

EID: 84921029160     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5030709     Document Type: Article

References (45)

1. WHO. Obesity and Overweight. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed on 23 July 2014).
2. Malik, V.S.; Willett, W.C.; Hu, F.B. Global obesity: Trends, risk factors and policy implications. Nat. Rev. Endocrinol. 2013, 9, 13–27.
3. Maes, H.H.; Neale, M.C.; Eaves, L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav. Genet. 1997, 27, 325–351.
4. El-Sayed Moustafa, J.S.; Froguel, P. From obesity genetics to the future of personalized obesity therapy. Nat. Rev. Endocrinol. 2013, 9, 402–413.
5. Loos, R.J. Genetic determinants of common obesity and their value in prediction. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26, 211–226.
6. Farooqi, S.; O’Rahilly, S. Genetics of obesity in humans. Endocr. Rev.2006, 27, 710–718.
7. Asai, M.; Ramachandrappa, S.; Joachim, M.; Shen, Y.; Zhang, R.; Nuthalapati, N.; Ramanathan, V.; Strochlic, D.E.; Ferket, P.; Linhart, K.; et al. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 2013, 341, 275–278.
8. Bamshad, M.J.; Ng, S.B.; Bigham, A.W.; Tabor, H.K.; Emond, M.J.; Nickerson, D.A.; Shendure, J. Exome sequencing as a tool for mendelian disease gene discovery. Nat. Rev. Genet. 2011, 12, 745–755.
9. Liew, W.K.; Ben-Omran, T.; Darras, B.T.; Prabhu, S.P.; de Vivo, D.C.; Vatta, M.; Yang, Y.; Eng, C.M.; Chung, W.K. Clinical application of whole-exome sequencing: A novel autosomal recessive spastic ataxia of charlevoix-saguenay sequence variation in a child with ataxia. JAMA Neurol. 2013, 70, 788–791.
10. Need, A.C.; Shashi, V.; Hitomi, Y.; Schoch, K.; Shianna, K.V.; McDonald, M.T.; Meisler, M.H.; Goldstein, D.B. Clinical application of exome sequencing in undiagnosed genetic conditions. J. Med. Genet. 2012, 49, 353–361.
11. Veltman, J.A.; Brunner, H.G. De novo mutations in human genetic disease. Nat. Rev. Genet. 2012, 13, 565–575.
12. Yang, Y.; Muzny, D.M.; Reid, J.G.; Bainbridge, M.N.; Willis, A.; Ward, P.A.; Braxton, A.; Beuten, J.; Xia, F.; Niu, Z.; et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013, 369, 1502–1511.
13. Gill, R.; Him Cheung, Y.; Shen, Y.; Lanzano, P.; Mirza, N.M.; Ten, S.; Maclaren, N.K.; Motaghedi, R.; Han, J.C.; Yanovski, J.A.; et al. Whole-exome sequencing identifies novel lepr mutations in individuals with severe early onset obesity. Obesity 2013, 22, 576–584.
14. Hendricks, A.E. Whole Exome Sequencing Case-Control Using 1000 Severe Obesity Cases Identifies Putative New Loci and Replicates Previously Established Loci; American Society of Human Genetics: Boston, MA, USA, 2013.
15. Scheidecker, S.; Etard, C.; Pierce, N.W.; Geoffroy, V.; Schaefer, E.; Muller, J.; Chennen, K.; Flori, E.; Pelletier, V.; Poch, O.; et al. Exome sequencing of bardet-biedl syndrome patient identifies a null mutation in the bbsome subunit bbip1 (bbs18). J. Med. Genet. 2014, 51, 132–136.
16. Gil, S.Y.; Youn, B.S.; Byun, K.; Huang, H.; Namkoong, C.; Jang, P.G.; Lee, J.Y.; Jo, Y.H.; Kang, G.M.; Kim, H.K.; et al. Clusterin and lrp2 are critical components of the hypothalamic feeding regulatory pathway. Nat. Commun. 2013, 4, 1862.
17. Fleury, C.; Neverova, M.; Collins, S.; Raimbault, S.; Champigny, O.; Levi-Meyrueis, C.; Bouillaud, F.; Seldin, M.F.; Surwit, R.S.; Ricquier, D.; et al. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 1997, 15, 269–272.
18. Berbari, N.F.; Pasek, R.C.; Malarkey, E.B.; Yazdi, S.M.; McNair, A.D.; Lewis, W.R.; Nagy, T.R.; Kesterson, R.A.; Yoder, B.K. Leptin resistance is a secondary consequence of the obesity in ciliopathy mutant mice. Proc. Natl. Acad. Sci. USA2013, 110, 7796–7801.
19. Mok, C.A.; Heon, E.; Zhen, M. Ciliary dysfunction and obesity. Clin. Genet. 2010, 77, 18–27.
20. Hama, H.; Saito, A.; Takeda, T.; Tanuma, A.; Xie, Y.; Sato, K.; Kazama, J.J.; Gejyo, F. Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology2004, 145, 3935–3940.
21. Dietrich, M.O.; Spuch, C.; Antequera, D.; Rodal, I.; de Yebenes, J.G.; Molina, J.A.; Bermejo, F.; Carro, E. Megalin mediates the transport of leptin across the blood-csf barrier. Neurobiol. Aging2008, 29, 902–912.
22. Aronow, B.J.; Lund, S.D.; Brown, T.L.; Harmony, J.A.; Witte, D.P. Apolipoprotein j expression at fluid-tissue interfaces: Potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. USA1993, 90, 725–729.
23. Pober, B.R.; Longoni, M.; Noonan, K.M. A review of donnai-barrow and facio-oculo-acoustico-renal (db/foar) syndrome: Clinical features and differential diagnosis. Birth Defects Res. Part A Clin. Mol. Teratol. 2009, 85, 76–81.
24. Chiu-Ugalde, J.; Theilig, F.; Behrends, T.; Drebes, J.; Sieland, C.; Subbarayal, P.; Kohrle, J.; Hammes, A.; Schomburg, L.; Schweizer, U. Mutation of megalin leads to urinary loss of selenoprotein p and selenium deficiency in serum, liver, kidneys and brain. Biochem. J. 2010, 431, 103–111.
25. May, P.; Woldt, E.; Matz, R.L.; Boucher, P. The ldl receptor-related protein (lrp) family: An old family of proteins with new physiological functions. Ann. Med. 2007, 39, 219–228.
26. Willnow, T.E.; Hilpert, J.; Armstrong, S.A.; Rohlmann, A.; Hammer, R.E.; Burns, D.K.; Herz, J. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. USA1996, 93, 8460–8464.
27. Ha, S.; Stottmann, R.W.; Furley, A.J.; Beier, D.R. A forward genetic screen in mice identifies mutants with abnormal cortical patterning. Cereb. Cortex2013, doi:10.1093/cercor/bht209.
28. Kantarci, S.; Al-Gazali, L.; Hill, R.S.; Donnai, D.; Black, G.C.; Bieth, E.; Chassaing, N.; Lacombe, D.; Devriendt, K.; Teebi, A.; et al. Mutations in lrp2, which encodes the multiligand receptor megalin, cause donnai-barrow and facio-oculo-acoustico-renal syndromes. Nat. Genet. 2007, 39, 957–959.
29. Chen, H.H.; Lee, W.J.; Wang, W.; Huang, M.T.; Lee, Y.C.; Pan, W.H. Ala55val polymorphism on ucp2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding. Obes. Surg. 2007, 17, 926–933.
30. Oktavianthi, S.; Trimarsanto, H.; Febinia, C.A.; Suastika, K.; Saraswati, M.R.; Dwipayana, P.; Arindrarto, W.; Sudoyo, H.; Malik, S.G. Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc. Diabetol. 2012, 11, 41.
31. Buemann, B.; Schierning, B.; Toubro, S.; Bibby, B.M.; Sorensen, T.; Dalgaard, L.; Pedersen, O.; Astrup, A. The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 467–471.
32. Knowles, M.R.; Daniels, L.A.; Davis, S.D.; Zariwala, M.A.; Leigh, M.W. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am. J. Respir. Crit. Care Med. 2013, 188, 913–922.
33. Bell, C.G.; Meyre, D.; Samson, C.; Boyle, C.; Lecoeur, C.; Tauber, M.; Jouret, B.; Jaquet, D.; Levy-Marchal, C.; Charles, M.A.; et al. Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity. Diabetes2005, 54, 3049–3055.
34. Cota, D.; Proulx, K.; Smith, K.A.; Kozma, S.C.; Thomas, G.; Woods, S.C.; Seeley, R.J. Hypothalamic mtor signaling regulates food intake. Science2006, 312, 927–930.
35. Davenport, J.R.; Watts, A.J.; Roper, V.C.; Croyle, M.J.; van Groen, T.; Wyss, J.M.; Nagy, T.R.; Kesterson, R.A.; Yoder, B.K. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. CB2007, 17, 1586–1594.
36. Marion, V.; Stoetzel, C.; Schlicht, D.; Messaddeq, N.; Koch, M.; Flori, E.; Danse, J.M.; Mandel, J.L.; Dollfus, H. Transient ciliogenesis involving bardet-biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc. Natl. Acad. Sci. USA2009, 106, 1820–1825.
37. Sen Gupta, P.; Prodromou, N.V.; Chapple, J.P. Can faulty antennae increase adiposity? The link between cilia proteins and obesity. J. Endocrinol. 2009, 203, 327–336.
38. Szabo, N.E.; Zhao, T.; Cankaya, M.; Theil, T.; Zhou, X.; Alvarez-Bolado, G. Role of neuroepithelial sonic hedgehog in hypothalamic patterning. J. Neurosci. 2009, 29, 6989–7002.
39. British 1958 birth cohort DNA Collection. Available online: http://www.b58cgene.sgul.ac.uk/ (accessed on 23 July 2014).
40. Wang, K.; Zhang, H.; Bloss, C.S.; Duvvuri, V.; Kaye, W.; Schork, N.J.; Berrettini, W.; Hakonarson, H.; Price Foundation Collaborative Group. A genome-wide association study on common snps and rare cnvs in anorexia nervosa. Mol. Psychiatry 2011, 16, 949–959.
41. Brondani, L.A.; Assmann, T.S.; de Souza, B.M.; Boucas, A.P.; Canani, L.H.; Crispim, D. Meta-analysis reveals the association of common variants in the uncoupling protein (ucp) 1–3 genes with body mass index variability. PLoS One2014, 9, e96411.
42. Tan, L.J.; Zhu, H.; He, H.; Wu, K.H.; Li, J.; Chen, X.D.; Zhang, J.G.; Shen, H.; Tian, Q.; Krousel-Wood, M.; et al. Replication of 6 obesity genes in a meta-analysis of genome-wide association studies from diverse ancestries. PLoS One2014, 9, e96149.
43. MacArthur, D.G.; Manolio, T.A.; Dimmock, D.P.; Rehm, H.L.; Shendure, J.; Abecasis, G.R.; Adams, D.R.; Altman, R.B.; Antonarakis, S.E.; Ashley, E.A.; et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014, 508, 469–476.
44. Beaulieu, C.L.; Majewski, J.; Schwartzentruber, J.; Samuels, M.E.; Fernandez, B.A.; Bernier, F.P.; Brudno, M.; Knoppers, B.; Marcadier, J.; Dyment, D.; et al. Forge canada consortium: Outcomes of a 2-year national rare-disease gene-discovery project. Am. J. Hum. Genet. 2014, 94, 809–817.
45. Rabbani, B.; Tekin, M.; Mahdieh, N. The promise of whole-exome sequencing in medical genetics. J. Hum. Genet. 2014, 59, 5–15.